Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Thrombosomes® in Bleeding Thrombocytopenic Patients Study


This prospective, multicenter, randomized, open-label, Phase 2, parallel, dose ranging, multidose trial will enroll patients into 3 Thrombosomes dose groups and 1 control liquid stored platelets (LSP) group in order to evaluate, in a dose-escalation manner, the safety, and impact on bleeding, and the preliminary effect on coagulation measures of increasing doses of allogeneic Thrombosomes in comparison to standard of care, LSP.
Sharma, Deva

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: